Lacripep for Corneal Wound Healing Study

PHASE2RecruitingINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

May 23, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

September 30, 2027

Conditions
Corneal Epithelial Wound Healing
Interventions
DRUG

0.00025% Lacripep ophthalmic solution and Placebo

Participant will receive Lacripep in one eye and placebo in the other eye at the same time.

Trial Locations (1)

22060

RECRUITING

Alexander T. Augusta Military Medical Center, Fort Belvoir

All Listed Sponsors
collaborator

TearSolutions, Inc.

INDUSTRY

collaborator

Walter Reed National Military Medical Center

FED

lead

Henry M. Jackson Foundation for the Advancement of Military Medicine

OTHER

NCT06854393 - Lacripep for Corneal Wound Healing Study | Biotech Hunter | Biotech Hunter